QQQ   423.79 (-0.48%)
AAPL   166.82 (-0.70%)
MSFT   407.03 (-1.17%)
META   504.13 (+2.02%)
GOOGL   156.41 (+0.60%)
AMZN   179.27 (-1.11%)
TSLA   149.86 (-3.60%)
NVDA   845.64 (+0.63%)
AMD   154.30 (+0.18%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.76 (-3.07%)
GE   154.45 (-0.78%)
CGC   7.89 (+21.57%)
DIS   112.85 (-0.08%)
AMC   2.89 (-3.02%)
PFE   25.27 (-0.59%)
PYPL   62.27 (-1.56%)
XOM   118.43 (-0.17%)
QQQ   423.79 (-0.48%)
AAPL   166.82 (-0.70%)
MSFT   407.03 (-1.17%)
META   504.13 (+2.02%)
GOOGL   156.41 (+0.60%)
AMZN   179.27 (-1.11%)
TSLA   149.86 (-3.60%)
NVDA   845.64 (+0.63%)
AMD   154.30 (+0.18%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.76 (-3.07%)
GE   154.45 (-0.78%)
CGC   7.89 (+21.57%)
DIS   112.85 (-0.08%)
AMC   2.89 (-3.02%)
PFE   25.27 (-0.59%)
PYPL   62.27 (-1.56%)
XOM   118.43 (-0.17%)
QQQ   423.79 (-0.48%)
AAPL   166.82 (-0.70%)
MSFT   407.03 (-1.17%)
META   504.13 (+2.02%)
GOOGL   156.41 (+0.60%)
AMZN   179.27 (-1.11%)
TSLA   149.86 (-3.60%)
NVDA   845.64 (+0.63%)
AMD   154.30 (+0.18%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.76 (-3.07%)
GE   154.45 (-0.78%)
CGC   7.89 (+21.57%)
DIS   112.85 (-0.08%)
AMC   2.89 (-3.02%)
PFE   25.27 (-0.59%)
PYPL   62.27 (-1.56%)
XOM   118.43 (-0.17%)
QQQ   423.79 (-0.48%)
AAPL   166.82 (-0.70%)
MSFT   407.03 (-1.17%)
META   504.13 (+2.02%)
GOOGL   156.41 (+0.60%)
AMZN   179.27 (-1.11%)
TSLA   149.86 (-3.60%)
NVDA   845.64 (+0.63%)
AMD   154.30 (+0.18%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.23 (+0.68%)
F   12.03 (-0.08%)
MU   112.76 (-3.07%)
GE   154.45 (-0.78%)
CGC   7.89 (+21.57%)
DIS   112.85 (-0.08%)
AMC   2.89 (-3.02%)
PFE   25.27 (-0.59%)
PYPL   62.27 (-1.56%)
XOM   118.43 (-0.17%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
$1.48
-9.2%
$2.88
$0.73
$6.60
$16.90M1.173.10 million shs90,008 shs
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
$10.37
$0.02
$0.20
$24.13M0.4314.24 million shs6.96 million shs
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
$0.39
+5.4%
$0.37
$0.80
$1.82
$3.53M2.034,760 shs90,000 shs
International Stem Cell Co. stock logo
ISCO
International Stem Cell
$0.07
$0.09
$0.05
$0.19
N/A0.521,355 shs1,803 shs
Kaya Holdings, Inc. stock logo
KAYS
Kaya
$0.03
$0.04
$0.03
$0.09
$456K0.582,729 shs815 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
-9.20%-26.00%-12.43%-38.33%+24.37%
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
0.00%-99.02%-99.32%-96.72%+429.41%
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
-0.46%-9.76%-6.49%-8.14%-0.46%
International Stem Cell Co. stock logo
ISCO
International Stem Cell
+0.14%-6.07%-16.24%-12.21%-60.04%
Kaya Holdings, Inc. stock logo
KAYS
Kaya
-12.68%0.00%-22.50%-22.50%-43.33%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
N/AN/AN/AN/AN/AN/AN/AN/A
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/AN/AN/AN/AN/AN/AN/AN/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/A
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
N/AN/AN/AN/A
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/AN/AN/AN/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/AN/AN/AN/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/A$1.57 per shareN/A
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
N/AN/AN/A1.20N/AN/A
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/AN/AN/AN/A($0.07) per shareN/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
$7.79MN/AN/AN/A($0.57) per shareN/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
$200K2.28N/AN/A($1.20) per share-0.03

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
-$8.75MN/A0.00N/AN/AN/AN/AN/A
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
$1.05M-$0.08N/AN/AN/AN/AN/A-347.62%N/A
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
-$1.11M-$0.40N/AN/AN/AN/A-288.85%N/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
-$130K-$0.03N/AN/A-2.68%-2.80%-3.77%N/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
-$3.58M-$0.02N/AN/A1,094.83%-17.93%757.70%4/26/2024 (Estimated)

Latest ICOTF, KAYS, EARS, ISCO, and EMBI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/A-$0.04-$0.04-$0.04N/A$1.89 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/AN/AN/AN/AN/A
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
N/AN/AN/AN/AN/A
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/AN/AN/AN/AN/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/AN/AN/AN/AN/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/A
3.83
3.83
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
0.43
3.59
3.59
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/A
0.72
0.72
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/A
0.73
0.47
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/A
0.02
0.01

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
6.03%
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
5.58%
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
N/A
Kaya Holdings, Inc. stock logo
KAYS
Kaya
N/A

Insider Ownership

CompanyInsider Ownership
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
N/A
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
1.60%
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/A
International Stem Cell Co. stock logo
ISCO
International Stem Cell
67.97%
Kaya Holdings, Inc. stock logo
KAYS
Kaya
23.52%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Auris Medical Holding Ltd. stock logo
EARS
Auris Medical
132,20011.42 millionN/ANot Optionable
Emerald Bioscience Inc. stock logo
EMBI
Emerald Bioscience
4268.07 millionN/ANot Optionable
iCo Therapeutics Inc. stock logo
ICOTF
iCo Therapeutics
N/A9.05 millionN/ANot Optionable
International Stem Cell Co. stock logo
ISCO
International Stem Cell
29N/AN/ANot Optionable
Kaya Holdings, Inc. stock logo
KAYS
Kaya
414.72 million11.26 millionNot Optionable

ICOTF, KAYS, EARS, ISCO, and EMBI Headlines

SourceHeadline
In ‘Temple Folk,’ Aspen Words Literary Prize finalist Aaliyah Bilal pursues ‘the practice of empathy through literature’In ‘Temple Folk,’ Aspen Words Literary Prize finalist Aaliyah Bilal pursues ‘the practice of empathy through literature’
aspenpublicradio.org - April 18 at 9:18 AM
Kaya Werley powers Wilson WL past Fleetwood with 3 home runsKaya Werley powers Wilson WL past Fleetwood with 3 home runs
wfmz.com - April 18 at 9:18 AM
Tuesdays Prep Roundup: Anacortes girls tennis team sweeps Sedro-WoolleyTuesday's Prep Roundup: Anacortes girls' tennis team sweeps Sedro-Woolley
goskagit.com - April 17 at 2:03 PM
KAYS Stock Earnings: Kaya Holdings Reported Results for Q4 2023KAYS Stock Earnings: Kaya Holdings Reported Results for Q4 2023
msn.com - April 17 at 12:48 AM
Here are Orlandos best restaurants, as named by Fodors Travel guideHere are Orlando's best restaurants, as named by Fodor's Travel guide
bizjournals.com - April 15 at 7:19 PM
‘The Gentlemen Stars Theo James, Kaya Scodelario & Daniel Ings Talk Prospect Of Second Season For Guy Ritchies Netflix Series - Contenders TV‘The Gentlemen' Stars Theo James, Kaya Scodelario & Daniel Ings Talk Prospect Of Second Season For Guy Ritchie's Netflix Series - Contenders TV
msn.com - April 15 at 3:37 PM
Marvin Agustin, pabirong nag-react sa pagkakilig ni Jolina Magdangal kay Kim Seon Ho: "Kaya pala"Marvin Agustin, pabirong nag-react sa pagkakilig ni Jolina Magdangal kay Kim Seon Ho: "Kaya pala"
msn.com - April 15 at 8:58 AM
18 Behind-The-Scenes Secrets You Probably Didn’t Know About The Gentlemen18 Behind-The-Scenes Secrets You Probably Didn’t Know About The Gentlemen
ca.news.yahoo.com - April 14 at 7:57 AM
ABOUT THE SHOWABOUT THE SHOW
gmanetwork.com - April 12 at 8:51 PM
The Information promotes Yurieff to team leaderThe Information promotes Yurieff to team leader
talkingbiznews.com - April 12 at 6:30 PM
Mum of teen who died after six-week cancer battle launches charity to pay for kids MRI scansMum of teen who died after six-week cancer battle launches charity to pay for kids' MRI scans
msn.com - April 12 at 6:30 PM
Enjoy The New Gujarati Music Video For Kaya Choghadiye Thayo Hato Prem Sung By Kishan RavalEnjoy The New Gujarati Music Video For Kaya Choghadiye Thayo Hato Prem Sung By Kishan Raval
timesofindia.indiatimes.com - April 12 at 8:28 AM
Sizwe Dhlomo Dispels Rumours of Sol Phenduka’s Departure From Kaya 959: “He’s Not Going Anywhere”Sizwe Dhlomo Dispels Rumours of Sol Phenduka’s Departure From Kaya 959: “He’s Not Going Anywhere”
msn.com - April 12 at 8:28 AM
Allison Hanes: When will Quebec finally take proper action on pedestrian deaths?Allison Hanes: When will Quebec finally take proper action on pedestrian deaths?
msn.com - April 11 at 11:25 PM
Get The Gentleman’s Kaya Scodelario’s look from £15 & the other TV shows that are taking over fashionGet The Gentleman’s Kaya Scodelario’s look from £15 & the other TV shows that are taking over fashion
thesun.co.uk - April 11 at 1:23 PM
Get The Gentleman’s Kaya Scodelario’s look from £15 PLUS other stylish TV shows that are taking over fashionGet The Gentleman’s Kaya Scodelario’s look from £15 PLUS other stylish TV shows that are taking over fashion
thesun.ie - April 11 at 8:23 AM
Kaya Scodelario Called Out The Lack Of "Safeguarding" During Her Time On "Skins," Days After Dev Patel Spoke About The "Insane" Shoots They HadKaya Scodelario Called Out The Lack Of "Safeguarding" During Her Time On "Skins," Days After Dev Patel Spoke About The "Insane" Shoots They Had
yahoo.com - April 10 at 8:24 PM
The Gentleman’s Kaya Scodelario’s rise from C4 drama to star of Netflix hit and why she has a strict ‘no a**eholes’ ruleThe Gentleman’s Kaya Scodelario’s rise from C4 drama to star of Netflix hit and why she has a strict ‘no a**eholes’ rule
thesun.co.uk - April 10 at 5:04 PM
The Gentlemen Outfits: Where To Shop Kaya Scodelario’s Best Looks From Netflix’s New #1 ShowThe Gentlemen Outfits: Where To Shop Kaya Scodelario’s Best Looks From Netflix’s New #1 Show
msn.com - April 10 at 12:04 PM
Kaya Scodelario has called out Skins for lack of safeguardingKaya Scodelario has called out Skins for 'lack of safeguarding'
marieclaire.co.uk - April 10 at 12:04 PM
Sizwe Dhlomo confirms Glen Lewis’ joining of Kaya after station’s failed attempt to get AzaniaSizwe Dhlomo confirms Glen Lewis’ joining of Kaya after station’s failed attempt to get Azania
citizen.co.za - April 10 at 10:24 AM
There was no protection for teens on Skins, now I won’t tolerate bad behaviour & have strict rules, says Kaya ScodelarioThere was no protection for teens on Skins, now I won’t tolerate bad behaviour & have strict rules, says Kaya Scodelario
thesun.co.uk - April 10 at 10:24 AM
Kaya Scodelario calls out Skins for a lack of safeguarding for young castKaya Scodelario calls out Skins for a lack of 'safeguarding' for young cast
msn.com - April 10 at 10:24 AM
No more extension for PUV consolidation deadline — MarcosNo more extension for PUV consolidation deadline — Marcos
philstar.com - April 10 at 7:03 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Auris Medical logo

Auris Medical

NASDAQ:EARS
Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
Emerald Bioscience logo

Emerald Bioscience

OTCMKTS:EMBI
Emerald Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111, which is in preclinical trials for the treatment of glaucoma. It is also developing NB2222, a product candidate in preclinical trials for use in the treatment of various eye diseases, including uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3111, a cannabinoid cocktail in testing for use as an anti-infective agent against various strains of antibiotic resistant bacteria, including methicillin-resistant Staphylococcus aureus. The company was formerly known as Nemus Bioscience, Inc. and changed its name to Emerald Bioscience, Inc. in March 2019. Emerald Bioscience, Inc. was founded in 2012 and is based in San Diego, California.
iCo Therapeutics logo

iCo Therapeutics

OTCMKTS:ICOTF
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.
International Stem Cell logo

International Stem Cell

OTCMKTS:ISCO
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury. The company also offers anti-aging skin care products, including ProPlus Advanced Defense Complex, ProPlus Advanced Recovery Complex, ProPlus Eye Firming Complex, ProPlus Neck Firming Complex, ProPlus Advanced Aqueous Treatment, ProPlus Collagen Booster, ProPlus Elastin Booster, and ProPlus Brightening Toner. In addition, it provides human cell culture products comprising human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.
Kaya logo

Kaya

OTCMKTS:KAYS
Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, produces, distributes, and/or sells a range of cannabis products primarily in the United States. The company offers flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. It also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. In addition, the company provides standing display cases with cannabis intended glassware under the Really Happy Glass brand; and t-shirt designs under the Kaya Gear brand name. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. was incorporated in 1993 and is headquartered in Fort Lauderdale, Florida.